Between carvedilol and timolol there was an overlap of 15 genes (Fig 4), causing an upregulation, among others, of GPER1, PDE4B and TNFAIP3, which are genes directly associated with hypertension [27–29]. Here, PDE4B is linked to hypertensive disorder.